Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 19, 2023

Biomarker-Integrated Targeted Agents as Second-Line Therapy in Patients With Advanced Gastric Cancer

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study
J. Clin. Oncol 2023 Oct 26;[EPub Ahead of Print], CK Lee, HS Kim, M Jung, H Kim, WK Bae, DH Koo, HC Jeung, SR Park, IG Hwang, DY Zang, HW Lee, S Park, CM Nam, HC Chung, SY Rha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading